drugset / Trial / NCT00035503
Multicenter Trial For Patients With Acute Crohn's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.
Timeline
- Start
- 2002-01-31
- Primary completion
- 2004-01-31
- Completion
- 2004-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | etiprednol dicloacetate | Small molecule | — | — |